Covid-19 Update

Stephen Hammond Excerpts

Tuesday 2nd February 2021 Commons Chamber

[Matt Hancock]

The hon. Lady is absolutely right to ask this critical question. We are doing a huge amount with the scientists and the pharmaceutical industry to develop modified vaccines should they be necessary. We are also monitoring the results of work to understand the efficacy of the existing vaccines against the variants of concern. We do not have a point estimate for the difference in the efficacy of the vaccine. The efficacy needs to be measured both in terms of someone’s likelihood of catching the disease and in terms of their likelihood of being hospitalised or dying from the disease. There is a significant amount of work under way to understand all those things, both in labs and in the field. For instance, AstraZeneca has a trial in South Africa that it is revisiting to understand the progress of those who were vaccinated as part of the trial. We will publish as much information as we get as soon as we credibly can. I wish I could give a number in answer to the hon. Lady’s very astute question, but unfortunately it is not scientifically credibly available yet.

[Stephen Hammond (Wimbledon) (Con) [V]]

I congratulate my right hon. Friend on his decisions of last year to guarantee the surplus supplies of vaccine, and I thank all the NHS staff and volunteers in Wimbledon who are delivering it. Clearly, getting the vaccine rolled out as fast as possible is key. Therefore, can he confirm that he will make sure that best practice advice is being given to every vaccine centre to ensure that there are no supplies unused at the end of the day and that there is a reserve list for appointments?

[Matt Hancock]

The vaccine programme has been enormous hard work by a huge number of people. It is very heartening to see it progress as it is, including in Wimbledon, where it is going well, and I am very grateful for my hon. Friend’s support in making that happen. The need to use every last drop of this precious vaccine is paramount. The standard operating protocol clearly states that all vaccine doses that are available should be used. If we can get 11 doses out of the 10-dose AstraZeneca vial, then we should do so. It is now standard practice to get six doses out of the previously five-dose Pfizer vial. There should also be a reserve list of people in categories 1 to 4 who can be called up at the end of the day if there is any spare. But the most important thing is that if the vaccine is going off—if it is coming to the end of its time out of the freezer, for the Pfizer jab—then it should be used in all circumstances. We need to use every last drop.